Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

GSK

Mentioned in 6 analyzed podcast episodes across 4 shows

Episode Mentions

Pharma and BioTech Daily

Pharma and BioTech Daily · May 13, 2026

Pfizer's $85M Breast Cancer Deal & FDA Shakeup | Pharma and Biotech Daily

Partnered with Sino Biopharmaceutical to distribute beperoversin for hepatitis B across China

FDA Leadership Transition and Regulatory StrategyPrecision Oncology and Targeted Breast Cancer TherapiesBiosimilar Competition and Market Erosion
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · Apr 30, 2026

AstraZeneca's £300M UK Investment Resumes Amid FDA Pilot | Pharma and Biotech Daily

Refocusing strategy on oncology; withdrew from Mursana Therapeutics partnership and paused mRNA bird flu shot program

FDA Real-Time Clinical Trial Review PilotAstraZeneca UK Investment and Drug PricingOncology Market Consolidation Strategy
View Analysis
Vital Dawn

Vital Dawn · Apr 29, 2026

Vital Dawn Podcast for Wednesday April 29

European healthcare company with disappointing Q1 earnings results

Q1 2024 Earnings Season Peak VolumeSemiconductor Industry AI Demand TrendsConsumer Spending Resilience
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · Apr 29, 2026

AstraZeneca's Breztri Asthma Approval Boosts $80B Goal | Pharma and Biotech Daily

Engaged in legal dispute with Anaptis Bio over Gemperely royalties, highlighting IP complexity in partnerships

FDA Drug Approval and RescissionData Integrity in Drug DevelopmentAI-Designed Therapeutics
View Analysis
The a16z Show

The a16z Show · Feb 16, 2026

Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company

Joint venture partner for Novartis consumer health business before spin-off

Corporate transformation and spin-offsCell and gene therapy platformsRNA therapeutics and siRNA technology
View Analysis
This Week in Virology

This Week in Virology · Jan 31, 2026

TWiV 1292: Clinical update with Dr. Daniel Griffin

Manufacturer of Shingrix vaccine discussed for use in adults under 50 for shingles and dementia prevention

WHO Withdrawal and Global Health GovernanceVaccine Hesitancy and Immunization PolicyMeasles Resurgence and Elimination Status
View Analysis